Ra Capital Management reported a 0% stake in UroGen Pharma URGN · 0 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 0%
Last report: 7% · filed 25/05/15
Shares held: 0 sh
Class: Ordinary Shares, par value NIS 0.01 per share
Stock: UroGen Pharma URGN
Holder: Ra Capital Management
Event date: 25/06/30
Filed: 25/08/14

0% stake · fully exited

Stake: 0%
Last report: 7%
Since last report: −7.0pp

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Ra Capital Management's other 5% stake reports

Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stake
Corbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
Ra Capital Management
5% stakeBetterLife Pharma
5% stake
BetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
Ra Capital Management
5% stakeSionna Therapeutics
5% stake
Sionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
Ra Capital Management
5% stakeTyra Biosciences
5% stake
Tyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
Ra Capital Management
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03